Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: Evidence from cDNA Array

Synapse

Volumn 41, Issue 1, 2001, Pages 40-48

  Cadet, Jean Lud ^a   Jayanthi, Subramaniam ^a   McCoy, Michael T ^a   Vawter, Marquis ^a   Ladenheim, Bruce ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Apoptosis; CDNA array; Neurotoxicity; Transcription factors

Indexed keywords

COMPLEMENTARY DNA; METHAMPHETAMINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL DEATH; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; GENE ACTIVATION; GENE EXPRESSION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CLUSTER ANALYSIS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; MALE; METHAMPHETAMINE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0035018447     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1058     Document Type: Article

References (58)

1. Adams JM, Cory S. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326.
2. Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P, Fornace AJ Jr. 1999. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18:3666-3672.
3. Beilharz EJ, Russo VC, Butler G, Baker NL, Connor B, Sirimanne ES, Dragunow M, Werther GA, Gluckman PD, Williams CE, Scheepens A. 1998. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res 59:119-134.
4. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. 2000. Genetic polymorphisms in the cathepsin D and interluekin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 288:21-24.
5. Bratton SB, MacFarlane M, Cain K, Cohen GM. 2000. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 256:27-33.
6. Bromberg J, Darnell JE Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473.
7. Cadet JL, Brannock C. 1998. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117-131.
8. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C. 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/ zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
9. Cadet JL, Ordonez SV, Ordonez JV. 1997. Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25:176-184.
10. Chapman HA, Munger JS, Shi GP. 1998. The role of thiol proteases in tissue injury and remodeling. Am J Respir Crit Care Med 150: S155-159.
11. Chen C, Edelstein LC, Gelinas C. 2000. The rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687-2695.
12. Clark DA, Coker R. 1998. Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol 30:293-298.
13. Cubells JF, Rayport S, Rajndron G, Sulzer D. 1994. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260-2271.
14. Dagnino J, Zhu L, Skorecki KL, Moses HL. 1995. E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins. Cell Growth Differ 6:191-198.
15. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
16. Deng X, Cadet JL. 1999. Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res 851:254-257.
17. Deng X, Cadet JL. 2000. Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice. Mol Brain Res 83:121-124.
18. Deng X, Ladenheim B, Tsao LI, Cadet JL. 1999. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19:10107-10115.
19. DeRisi JL, Iyer VR. 1999. Genomics and array technology. Curr Opin Oncol 11:76-79.
20. DeRisi JL, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. 1996. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457-460.
21. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P. 2000. Proinflammatory cytokines and interleukin-9 exacerbate excitotic lesions of the newborn murine neopallium. Ann Neurol 47:54-63.
22. Eisch AJ, Schmued LC, Marshall JF. 1998. Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse 30:329-333.
23. Ernst T, Chang L, Leonido-Yee M, Speck O. 2000. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54:1344-1349.
24. Fawcett TW, Martindale JL, Guyton KZ, Hat T, Holbrook NJ. 1999. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 339:134-141.
25. Ferrer I, Blanco R. 2000. N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Res Mol Brain Res 77:270-276.
26. Flanders KC, Ren RF, Lippa CF. 1998. Transforming growth factor-betas in neurodegenerative diseases. Prog Neurobiol 54:71-85.
27. Fukumura M, Cappon GD, Pu C, Broening HW, Vorhees CV. 1998. A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res 806:1-7.
28. Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. 1999. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19:2424-2431.
29. Glazner GW, Mattson MP. 2000. Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Exp Neurol 16:442-452.
30. Hagemann C, Rapp UR. 1999. Isotype-specific functions of Raf kinases. Exp Cell Res 253:34-46.
31. Harvey DC, Lacan G, Tanious SP, Melega WP. 2000. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 871:259-270.
32. Hirata H, Cadet JL. 1997. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies. J Neurochem 69:780-790.
33. Hirata H, Asanuma M, Cadet JL. 1998. Superoxide radicals are mediators of the effects of methamphetamine on Zif268 (Egr-1A) in the brain: evidence from using CuZn superoxide dismutase transgenic mice. Brain Res Mol Brain Res 58:209-216.
34. Itzhak Y, Gandia C, Huang PL, Ali SF. 1998. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284: 1040-1047.
35. Kamata H, Hirata H. 1999. Redox regulation of cellular signalling. Cell Signal 11:1-14.
36. Kerkhoff E, Rapp UR. 1998. Cell cycle targets of Ras/Raf signaling. Oncogene 17:1457-1462.
37. Kiefer R, Streit WJ, Toyka KV, Kreutzberg GW, Hartung HP. 1995. Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int J Dev Neurosci 13:331-339.
38. Krieglstein K, Suter-Crazzolara C, Unsicker K. 1995. Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily. J Neural Trans (Suppl) 46:209-216.
39. LaVoie MJ, Hastings TG. 1999. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484-1491.
40. Lee CK, Weindruch R, Prolla TA. 2000. Gene-expression profile of the aging brain in mice. Nat Genet 25:294-297.
41. Mattson MP, Culmsee C, Yu ZF. 2000. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301:173-187.
42. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18:8417-8422.
43. McCullough AK, Dodson ML, Lloyd RS. 1999. Initiation of base excision repair: glycosylase mechanisms and structures. Annu Rev Biochem 68:255-285.
44. Melega WP, Lacan G, Desalles AA, Phelps ME. 2000. Long-term methamphetamine-induced decreases of [(11)C]WIN 35, 428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey. Synapse 35:243-249.
45. O'Callaghan JP, Miller D. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751.
46. Owen-Schaub L, Chan H, Cusak JC, Roth J, Hill LL. 2000. Fas and Fas ligand interactions in malignant disease. Int J Oncol 17:5-12.
47. Pratt BM, McPherson JM. 1997. TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev 8:267-292.
48. Romashkova JA, Makarov SS. 1999. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401:86-90.
49. Schmued LC, Bowyer JF. 1997. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res 759:135-140.
50. Sheng P, Cerruti C, Ali S, Cadet JL. 1996. Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells. Ann NY Acad Sci 801:174-186.
51. Sonsalla PK, Nicklas WJ, Heikkila RE. 1989. Role for excitatory amino acids in methamphetamine-induced dopaminergic toxicity. Science 243:398-400.
52. Stumm G, Schlegel J, Schafer T, Wurz C, Mennel HD, Krieg JC, Vedder H. 1999. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J 13:1065-1072.
53. Talukder AH, Vadlamudi R, Mandal M, Kumar R. 2000. Heregulin induces expression DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4. Cancer Res 60:276-281.
54. Torres-Aleman I. 1999. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm Metab Res 31:114-119.
55. Wagner GC, Seiden LS, Schuster CR. 1979. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug Alcohol Depend 4:435-438.
56. Wagner AJ, Kokontis JM, Hay N. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip1. Genes Dev 8:2817-2830.
57. Walton M, Connor B, Lawlor P, Young D, Sirimanne E, Gluckman P, Cole G, Dragunow M. 1999. Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev 29:137-168.
58. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703.